Topiramate Tablet, Film Coated
Product Images NDC 71335-1147

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 71335-1147). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structured Product Formula For Topiramate (39703b05 F774 4aed 9792 000a61531553 01)

Structured Product Formula For Topiramate (39703b05 F774 4aed 9792 000a61531553 01)
Chemical structure diagram of the active ingredient topiramate, showing its distinct cyclic and functional groups.*
FDA Label Image

Structured Product Formula For Topiramate (39703b05 F774 4aed 9792 000a61531553 02)

Structured Product Formula For Topiramate (39703b05 F774 4aed 9792 000a61531553 02)
A line graph showing cumulative rates for time to first seizure over 500 days comparing topiramate 50 mg/day (solid line) and 400 mg/day (dashed line) in two groups of patients (N=234 and N=236). The graph indicates lower cumulative rates for the higher dose. A p-value of 0.0002 is displayed, suggesting statistical significance.*
FDA Label Image

Topiramate Tablets Usp (39703b05 F774 4aed 9792 000a61531553 03)

Topiramate Tablets Usp (39703b05 F774 4aed 9792 000a61531553 03)
A bar chart showing change from baseline to double-blind phase in average monthly migraine period rate (±SE) for placebo and various daily doses of topiramate (50 mg, 100 mg, 200 mg). The chart includes data from two studies (Study 11 and Study 12) with sample sizes indicated for each group. Statistically significant reductions compared to placebo are marked for higher doses of topiramate.*
FDA Label Image

Label (Lbl713351147)

Label (Lbl713351147)
Label for Topiramate 50 mg tablets packaged by Bryant Ranch Prepack in Burbank, CA. The label states the product is a white to off-white round tablet and is intended to be compared to Topamax 50 mg tablets by Cadila Healthcare Ltd. It includes storage instructions at room temperature (20°-25°C or 68°-77°F), the product NDC 71335-1147, and indicates a 30-count package.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.